FDA approves combination therapy for blurry vision
The FDA has approved Yuvezzi (carbachol and brimonidine tartrate), a once-daily eye drop to treat presbyopia in adults. Presbyopia is...
The FDA has approved Yuvezzi (carbachol and brimonidine tartrate), a once-daily eye drop to treat presbyopia in adults. Presbyopia is...
Muscle-invasive bladder cancer, representing approximately 25% of all bladder cancer cases, is typically managed with radical cystectomy combined with cisplatin-based...
Akums Drugs & Pharmaceuticals Ltd. on Tuesday announced the launch of a pioneering Ripasudil-Timolol combination therapy for glaucoma treatment. Glaucoma...
Market Closed - London S.E. 11:35:16 2025-01-31 am EST 5-day change 1st Jan Change 1,405.00 GBX +0.21% +3.58% +4.34% January...